合肥UPS國際快遞 新站區(qū)UPS國際快遞寄件網(wǎng)點(diǎn) 新站區(qū)USP國際快遞 新站區(qū)UPS公司地址 新站區(qū)UPS美國專線雙清包稅到門！

　　UPS 會捐贈的 200 萬美元現(xiàn)金和 100 萬美元的 UPS 實(shí)物服務(wù)，再加上來自Gavi 匹配的200 萬美元的匹配，總共產(chǎn)生了 500 萬美元，用于擴(kuò)大以前的共同努力由組織。該貢獻(xiàn)將適用于 Gavi 的 2021 年至 2025 年戰(zhàn)略時期。Gavi Matching Fund 成立于 2011 年，旨在鼓勵企業(yè)投資全球免疫。

　　這一承諾延續(xù)了 UPS 會和 UPS 與 Gavi 的長期合作伙伴關(guān)系，并利用了該公司在醫(yī)療保健供應(yīng)鏈管理方面的深厚知識。UPS 會與 Gavi 的企業(yè)合作伙伴關(guān)系始于 2014 年。 從那時起，UPS 提供資金和技術(shù)專長，旨在建立可靠的冷鏈網(wǎng)絡(luò)、擴(kuò)大疫苗的一英里交付、擴(kuò)大優(yōu)先國家受過培訓(xùn)的供應(yīng)鏈管理人員庫并帶頭創(chuàng)新。

　　“強(qiáng)大而高效的供應(yīng)鏈對 Gavi 的工作至關(guān)重要，”Gavi 執(zhí)行官 Seth Berkley 博士說?！霸?UPS 會的支持下，我們近年來已經(jīng)能夠極大地擴(kuò)大和改善符合 Gavi 資格的國家所依賴的供應(yīng)鏈，即使在世界上一些偏遠(yuǎn)的地區(qū)也是如此。我們非常感謝 UPS 會，它與 Gavi 的密切合作取得了真正突破性的成就。我們很高興能夠推動這一富有成果的關(guān)系的下一章?！?/p>

　　“作為一個以目標(biāo)為導(dǎo)向的全球組織，我們對 Gavi 使命的支持可以以重要的方式推動我們的社會——我們孩子的未來——并催化更多私營部門的支持，”UPS 會總裁兼 UPS 執(zhí)行官愛德華多·馬丁內(nèi)斯 (Eduardo Martinez) 說多元化、公平和包容性官員。“我們渴望為公共部門和民間社會創(chuàng)造途徑，以更好地與私營部門聯(lián)系，創(chuàng)建更有效的系統(tǒng)，并實(shí)現(xiàn)創(chuàng)新，以改善重要的衛(wèi)生服務(wù)和疫苗等商品的提供?！?/p>

　　在烏干達(dá)和衛(wèi)生部長的支持下，UPS 和 Gavi 于 2018 年 7 月在烏干達(dá)坎帕拉周邊的三個地區(qū)開發(fā)了一個試點(diǎn)一英里疫苗遞送網(wǎng)絡(luò)，為 300 萬人提供服務(wù)，并專注于提高接受疫苗接種的烏干達(dá)兒童的百分比兒童疫苗。UPS、Gavi 和 UPS 的授權(quán)服務(wù)承包商與烏干達(dá)衛(wèi)生部合作，建立了覆蓋 150 多個診所的疫苗遞送系統(tǒng)。該試點(diǎn)受到當(dāng)?shù)匦l(wèi)生網(wǎng)絡(luò)的好評，利用冷鏈實(shí)踐、帶冰箱的車輛、溫度監(jiān)測工具、庫存管理系統(tǒng)來跟蹤庫存并在疫苗缺貨之前觸發(fā)訂購。

　　UPS 會的捐款支持戰(zhàn)略培訓(xùn)執(zhí)行計劃 (STEP) 領(lǐng)導(dǎo)力發(fā)展計劃等活動，該計劃旨在培養(yǎng)供應(yīng)鏈管理人員提供疫苗供應(yīng)鏈端到端管理的能力。

　　UPS (NYSE:UPS) announced today that its freight forwarding operation at Changi Airport, Singapore, has received IATA CEIV Pharma Certification for pharmaceutical logistics. The certification is the first for UPS in Asia Pacific and strengthens the value proposition of UPS’s healthcare logistics offering in the region. It is a further validation of its capabilities in the safe, secure and efficient transportation of high-value pharmaceutical products.

　　IATA’s CEIV Pharma Certification is an industry certification developed by IATA, regulators and aviation industry stakeholders. It evaluates companies on a comprehensive range of criteria including management systems, facilities, e, operations and staff expertise. The certification requires companies to meet or exceed many existing pharmaceutical standards and guidelines such as IATA Temperature Control Regulations, European Union Good Distribution Practices, World Health Organisation Annex 5 Good Distribution Practices for Pharmaceutical Products and United States Pharmacopeia Standards.

　　“Pharmaceuticals are time and temperature-sensitive, re an extra amount of care throughout the transportation process. These are not typical packages, and at times life-saving deliveries as well. This certification is an affirmation of the high standards of handling and transportation that UPS’s customers in the healthcare and life sciences sector have come to rely on for their high-value shipments,” said Lim Bee Koong, Director, Healthcare Strategy, UPS Asia Pacific.

　　As a biomedical sciences hub for the Asia Pacific region, Singapore is home to eight of the top 10 pharmaceutical companies globally, manufacturing four of the top 10 drugs by global revenue2. With a third of scrapped pharmaceuticals globally attributed to logistics issues3, maintaining the integrity of the healthcare supply chain is crucial to Singapore’s biomedical manufacturing sector.

　　Enhancing its value proposition with an industry-leading set of standards like the IATA CEIV Pharma certification is part of UPS’s vision to inspire trust and empower innovation to improve patient care across the healthcare and life sciences ecosystem.